Portfolio company
Hybrigenics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides protein interaction screening services and nanobody selection to pharmaceutical, biotechnology, and academic researchers to support early-stage drug discovery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Single Cell Discoveries
This company provides single-cell sequencing and spatial transcriptomics services to pharmaceutical, biotechnology and academic organisations to support drug discovery and biological research.
Protillion Biosciences
This company develops a high-throughput protein engineering platform for pharmaceutical partners to accelerate the discovery and optimisation of therapeutic antibodies and binder drugs.
CrystalsFirst GmbH
This company provides structural biology and AI-driven drug discovery services to pharmaceutical and biotechnology organisations for small-molecule development.
DC Biosciences
DC Biosciences provides proteomics services and research tools to pharmaceutical and biotechnology companies to support drug discovery and development processes.
53Biologics
This company provides contract development and manufacturing services for recombinant proteins and plasmid DNA to biotechnology and pharmaceutical firms.
DropPrint Genomics
This company develops single-cell genomics software and an immune cell database for pharmaceutical researchers and biotechnology firms to improve drug discovery processes.
Abzena
This company provides discovery, development and manufacturing services for biologics and bioconjugates to biotechnology and pharmaceutical customers.
RoukenBio
This company provides immunology and bioassay research services for biopharmaceutical firms to support drug discovery and preclinical development.
